Drug Shortage Report for SANDOZ ESOMEPRAZOLE

Last updated on 2021-01-13 History
Report ID 128155
Drug Identification Number 02460939
Brand name SANDOZ ESOMEPRAZOLE
Common or Proper name SANDOZ ESOMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100GRT BO CA
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-06
Estimated end date 2020-12-25
Actual end date 2021-01-12
Shortage status Resolved
Updated date 2021-01-13
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-01-13 English Compare
v6 2021-01-12 French Compare
v5 2021-01-12 English Compare
v4 2020-12-14 French Compare
v3 2020-12-14 English Compare
v2 2020-11-09 French Compare
v1 2020-11-09 English Compare